Tensor Biosciences

At Tensor Bio, we’re pioneering the next generation of diagnostic tools for organ-specific diseases, starting with the liver. Using advanced epigenetics, machine learning, and cell-free DNA, we’re building accessible blood-based tests that deliver deep insights into conditions like MASH (formerly NASH). Our platform offers clinicians powerful tools to diagnose, stage, and monitor disease with precision—no biopsy required. We’re tackling some of the largest unmet needs in medicine, beginning with a silent epidemic affecting over 100 million people: metabolic dysfunction-associated steatotic liver disease (MASLD). With emerging therapies entering the market, Tensor Bio seeks to enable the timely and accurate identification of patients who stand to benefit, supporting better outcomes at scale. Backed by a team of Stanford scientists and seasoned biotech operators, our work is grounded in rigorous science, a spirit of collaboration, and a commitment to innovation that delivers real-world impact.